These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29212209)

  • 1. Targeted inhibition of glutaminase as a potential new approach for the treatment of
    Sheikh TN; Patwardhan PP; Cremers S; Schwartz GK
    Oncotarget; 2017 Nov; 8(55):94054-94068. PubMed ID: 29212209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
    Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
    J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer.
    Singleton DC; Dechaume AL; Murray PM; Katt WP; Baguley BC; Leung EY
    BMC Cancer; 2020 May; 20(1):470. PubMed ID: 32450839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
    PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.
    Boysen G; Jamshidi-Parsian A; Davis MA; Siegel ER; Simecka CM; Kore RA; Dings RPM; Griffin RJ
    Int J Radiat Biol; 2019 Apr; 95(4):436-442. PubMed ID: 30557074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma.
    Ye X; Zhou Q; Matsumoto Y; Moriyama M; Kageyama S; Komatsu M; Satoh S; Tsuchida M; Saijo Y
    Anticancer Res; 2016 Nov; 36(11):6021-6029. PubMed ID: 27793929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase.
    Liu Z; Wang J; Li Y; Fan J; Chen L; Xu R
    Tumour Biol; 2017 Feb; 39(2):1010428317691429. PubMed ID: 28218035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for exploring the allosteric inhibition of human kidney type glutaminase.
    Ramachandran S; Pan CQ; Zimmermann SC; Duvall B; Tsukamoto T; Low BC; Sivaraman J
    Oncotarget; 2016 Sep; 7(36):57943-57954. PubMed ID: 27462863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A facile and sensitive method of quantifying glutaminase binding to its inhibitor CB-839 in tissues.
    Chen Y; Zhao Y; Bajor DL; Wang Z; Selfridge JE
    J Genet Genomics; 2020 Jul; 47(7):389-395. PubMed ID: 33004309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
    Youngblood VM; Kim LC; Edwards DN; Hwang Y; Santapuram PR; Stirdivant SM; Lu P; Ye F; Brantley-Sieders DM; Chen J
    Cancer Res; 2016 Apr; 76(7):1825-36. PubMed ID: 26833123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.
    Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G
    Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular glutamate flux regulates intracellular glutaminase activity in LLC-PK1-F+ cells.
    Welbourne TC; Mu X
    Am J Physiol; 1995 Jun; 268(6 Pt 1):C1418-24. PubMed ID: 7611361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies.
    Wang Z; Liu F; Fan N; Zhou C; Li D; Macvicar T; Dong Q; Bruns CJ; Zhao Y
    Front Oncol; 2020; 10():589508. PubMed ID: 33194749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-PHB-glutaminase nanoparticle inhibits cancer cell proliferation in vitro through glutamine deprivation.
    Pandian SR; Deepak V; Nellaiah H; Sundar K
    In Vitro Cell Dev Biol Anim; 2015 Apr; 51(4):372-80. PubMed ID: 25424834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T Helper Cell Activation and Expansion Is Sensitive to Glutaminase Inhibition under Both Hypoxic and Normoxic Conditions.
    Sener Z; Cederkvist FH; Volchenkov R; Holen HL; Skålhegg BS
    PLoS One; 2016; 11(7):e0160291. PubMed ID: 27467144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy.
    Hoerner CR; Chen VJ; Fan AC
    Kidney Cancer; 2019 Feb; 3(1):15-29. PubMed ID: 30854496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy.
    Lukey MJ; Greene KS; Erickson JW; Wilson KF; Cerione RA
    Nat Commun; 2016 Apr; 7():11321. PubMed ID: 27089238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vemurafenib resistance reprograms melanoma cells towards glutamine dependence.
    Hernandez-Davies JE; Tran TQ; Reid MA; Rosales KR; Lowman XH; Pan M; Moriceau G; Yang Y; Wu J; Lo RS; Kong M
    J Transl Med; 2015 Jul; 13():210. PubMed ID: 26139106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutaminase inhibition in renal cell carcinoma therapy.
    Raczka AM; Reynolds PA
    Cancer Drug Resist; 2019; 2(2):356-364. PubMed ID: 35582719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaminase inhibition in multiple myeloma induces apoptosis
    Effenberger M; Bommert KS; Kunz V; Kruk J; Leich E; Rudelius M; Bargou R; Bommert K
    Oncotarget; 2017 Oct; 8(49):85858-85867. PubMed ID: 29156762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.